The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies law firms regulatory agencies and national and international industry associations. in Chemical Engineering from the University of Wisconsin-Madison. Beers holds a Bachelor of Chemical Engineering from Purdue University and a Ph.D. Beers was an assistant professor of chemical engineering at the Massachusetts Institute of Technology. He was previously the CEO of INTUS, a drug development platform that leverages proprietary biological network models to accelerate drug discovery.īefore starting his consulting career, Mr. Beers was a partner in an analytics company specializing in biopharma, medtech, and healthcare.
“Ken brings an impressive set of skills to the team in addition to supporting asset, portfolio, and business unit strategies for biopharmaceutical clients, we look forward to the focus he will bring to our continuing development of advanced analytics and strategic insights.” “We look forward to working with Ken to address our clients’ most complex challenges,” said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. “Ken will join a diverse team of recognized life sciences experts who assist clients with commercialization and branding strategies, policy issues, pricing and market access, litigation, and more.”
“We’re excited to welcome Ken Beers to CRA,” said CRA’s President and Chief Executive Officer Paul Maleh. His 15 years of industry experience spans therapeutic areas and modalities on early-stage, pre-commercialization, and in-line therapies, as well as the integration of technologies such as diagnostics, software-as-a-medical-device, and bioinformatics. Beers supports biopharmaceutical clients across a range of topics involving development and commercialization of novel therapies, portfolio management, and business unit strategy. Beers has joined CRA as a Vice President in the Company’s Life Sciences Practice.
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Kenneth J.
0 kommentar(er)
